Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.

被引：0
|
作者：
Saito, K. [1 ]
Uchida, K. [2 ]
Takahara, S. [3 ]
Yoshimura, N. [4 ]
Teraoka, S. [5 ]
Cornu-Artis, C. [6 ]
Kobayashi, E. [7 ]
Takahashi, K. [1 ]
机构：
[1] Niigata Univ, Niigata, Japan
[2] Aichi Med Univ, Aichi, Japan
[3] Osaka Univ, Osaka, Japan
[4] Kyoto Prefectural Univ Med, Kyoto, Japan
[5] Int Univ Hlth & Welf, Atami Hosp, Shizuoka, Japan
[6] Novartis Pharma AG, Basel, Switzerland
[7] Jichi Med Univ, Shimotsuke, Tochigi, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：314 / 314
页数：1
相关论文
共 50 条
  • [21] Safety Events of Interest with the De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Lehmkuhl, H.
    Hirt, S.
    Rinaldi, M.
    Bara, C.
    Zuckermann, A.
    Lopez, P.
    Cines, M.
    Dong, G.
    Keogh, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 74 - 75
  • [22] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients.
    Keown, P
    Ethgen, O
    Yang, XL
    Ricci, JF
    Kessabi, S
    Spaepen, S
    Annemans, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 504 - 504
  • [23] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients in Hungary
    Kósa, J
    Yang, X
    Kiss, É
    Kaló, Z
    VALUE IN HEALTH, 2005, 8 (06) : A78 - A79
  • [24] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 80 - 80
  • [25] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80
  • [26] De Novo Use of Everolimus With Elimination or Minimization of Cyclosporine in Renal Transplant Recipients
    Novoa, P. A.
    Grinyo, J. M.
    Ramos, F. J. P.
    Errasti, P.
    Franco, A.
    Aldana, G.
    Pefaur, J.
    Marti-Cuadros, A. M.
    Otero, A. B.
    Saval, N.
    Oppenheimer, F.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (09) : 3331 - 3339
  • [27] Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients
    Lehmkuhl, Hans B.
    Arizon, Jose
    Vigano, Mario
    Almenar, Luis
    Gerosa, Gino
    Maccherini, Massimo
    Varnous, Shaida
    Musumeci, Francesco
    Hexham, J. Mark
    Mange, Kevin C.
    Livi, Ugolino
    TRANSPLANTATION, 2009, 88 (01) : 115 - 122
  • [28] Results of a 12-month, multicenter, randomized trial of everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in De Novo cardiac transplant recipients
    Lebmkuhl, H.
    Livi, U.
    Arizon, J.
    Vigano, M.
    Magelli, C.
    Boissonnat, P.
    Gerosa, G.
    Musumeci, F.
    Gandjbakhch, I.
    Vanhaecke, J.
    Hexham, J. M.
    Mange, K. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S65 - S65
  • [29] Everolimus in de novo heart transplant recipients:: Six month data on cyclosporine reduction and impact on renal function
    Keogh, A.
    Wang, S. S.
    Zuckermann, A.
    Ross, H.
    Frigerio, M.
    Eisen, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S202 - S202
  • [30] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Prokopenko, E. I.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
12345